Cargando…

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease

BACKGROUND: Chagas disease is a neglected zoonosis caused by the parasite Trypanosoma cruzi. It affects over six million people, mostly in Latin America. Drugs available to treat T. cruzi infection have associated toxicity and questionable efficacy at the chronic stage. Hence, the discovery of more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Peinado, Nieves, Cortes-Serra, Nuria, Tallini, Luciana R., Pinazo, Maria-Jesus, Gascon, Joaquim, Bastida, Jaume, Alonso-Padilla, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235838/ https://www.ncbi.nlm.nih.gov/pubmed/34174959 http://dx.doi.org/10.1186/s13071-021-04837-9

Ejemplares similares

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
por: Martinez-Peinado, Nieves, et al.
Publicado: (2020)

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)
por: Tallini, Luciana R., et al.
Publicado: (2018)

Alkaloid Constituents of the Amaryllidaceae Plant Amaryllis belladonna L.
por: Tallini, Luciana R., et al.
Publicado: (2017)

Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi
por: Ros-Lucas, Albert, et al.
Publicado: (2022)

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
por: Gabaldón-Figueira, Juan Carlos, et al.
Publicado: (2023)

Amaryllidaceae alkaloids: identification and partial characterization of montanine production in Rhodophiala bifida plant
por: Reis, Andressa, et al.
Publicado: (2019)

Alkaloid Composition and Biological Activities of the Amaryllidaceae Species Ismene amancaes (Ker Gawl.) Herb.
por: Soto-Vásquez, Marilú Roxana, et al.
Publicado: (2022)

N-oxide alkaloids from Crinum amabile (Amaryllidaceae)
por: Tallini, Luciana R., et al.
Publicado: (2018)

Structural Diversity and Biological Potential of Alkaloids from the Genus Hippeastrum, Amaryllidaceae: an Update
por: Tallini, Luciana R., et al.
Publicado: (2021)

Antileishmanial Activity of Clinanthus milagroanthus S. Leiva & Meerow (Amaryllidaceae) Collected in Peru
por: Soto-Vásquez, Marilú Roxana, et al.
Publicado: (2023)

Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Author Correction: Amaryllidaceae alkaloids: identification and partial characterization of montanine production in Rhodophiala bifida plant
por: Reis, Andressa, et al.
Publicado: (2019)

Alkaloid Profiling and Cholinesterase Inhibitory Potential of Crinum × amabile Donn. (Amaryllidaceae) Collected in Ecuador
por: Tallini, Luciana R., et al.
Publicado: (2021)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2019)

Chemical Survey of Three Species of the Genus Rauhia Traub (Amaryllidaceae)
por: Tallini, Luciana R., et al.
Publicado: (2022)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Hippeastrum reticulatum (Amaryllidaceae): Alkaloid Profiling, Biological Activities and Molecular Docking
por: Tallini, Luciana R., et al.
Publicado: (2017)

Chemical Profiling and Cholinesterase Inhibitory Activity of Five Phaedranassa Herb. (Amaryllidaceae) Species from Ecuador
por: Moreno, Raúl, et al.
Publicado: (2020)

Chemical and Biological Aspects of Different Species of the Genus Clinanthus Herb. (Amaryllidaceae) from South America
por: Rodríguez-Escobar, María Lenny, et al.
Publicado: (2023)

Alkaloids of Phaedranassa dubia (Kunth) J.F. Macbr. and Phaedranassa brevifolia Meerow (Amaryllidaceae) from Ecuador and its cholinesterase-inhibitory activity
por: León, Karen Acosta, et al.
Publicado: (2021)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
por: Pinto, Jimy-Jose, et al.
Publicado: (2019)

Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis
por: Egüez, Karina E., et al.
Publicado: (2017)

Acetylcholinesterase Inhibition Activity of Hippeastrum papilio (Ravenna) Van Scheepen (Amaryllidaceae) Using Zebrafish Brain Homogenates
por: Tallini, Luciana R., et al.
Publicado: (2023)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

Use of rapid diagnostic tests (RDTs) for conclusive diagnosis of chronic Chagas disease – field implementation in the Bolivian Chaco region
por: Lozano, Daniel, et al.
Publicado: (2019)

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against Trypanosoma cruzi
por: Martinez-Peinado, Nieves, et al.
Publicado: (2023)

Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2022)

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
por: Pinazo, Maria-Jesus, et al.
Publicado: (2015)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia
por: Pinazo, Maria-Jesus, et al.
Publicado: (2021)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
por: Pinazo, Maria-Jesus, et al.
Publicado: (2017)

Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Wild Argentinian Amaryllidaceae, a New Renewable Source of the Acetylcholinesterase Inhibitor Galanthamine and Other Alkaloids
por: Ortiz, Javier E., et al.
Publicado: (2012)

Alkaloids Analysis of Habranthus cardenasianus (Amaryllidaceae), Anti-Cholinesterase Activity and Biomass Production by Propagation Strategies
por: Zaragoza-Puchol, Daniel, et al.
Publicado: (2021)

Design of an Epitope-Based Vaccine Ensemble for Animal Trypanosomiasis by Computational Methods
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network
por: Pinazo, Maria-Jesus, et al.
Publicado: (2022)

High prevalence of S. Stercoralis infection among patients with Chagas disease: A retrospective case-control study
por: Puerta-Alcalde, Pedro, et al.
Publicado: (2018)

Chagas Disease among the Latin American Adult Population Attending in a Primary Care Center in Barcelona, Spain
por: Roca, Carme, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k2s0jfj2jmda9ejb9jmbr98qk2